# 510(k) Summary

# K121040

() Submitted by:

Diamond Diagnostics 333 Fiske St. Holliston, MA 01746

AUG 3 0 2012

Contact Person:

Liann Voo, Director of Quality Assurance and Scientific Development   
Phone: 508-429-0450 (x 351)   
Fax 508-429-0452   
E-mail: Ivoo@diamonddiagnostics.com

(3)Summary Prepared: March 26, 2012

Device Trade Name: SMARTLYTE Electrolyte Analyzer

Regulatory Information

<table><tr><td rowspan=1 colspan=1>Description</td><td rowspan=1 colspan=1>CFR Section</td><td rowspan=1 colspan=1>Device Class</td><td rowspan=1 colspan=1>Product Code</td></tr><tr><td rowspan=1 colspan=1>Sodium Test System</td><td rowspan=1 colspan=1>862.1665</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>JGS</td></tr><tr><td rowspan=1 colspan=1>Potassium Test System</td><td rowspan=1 colspan=1>862.1600</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>CEM</td></tr><tr><td rowspan=1 colspan=1>Chloride Test System</td><td rowspan=1 colspan=1>862.1170</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>CGZ</td></tr><tr><td rowspan=1 colspan=1>Calcium Test System</td><td rowspan=1 colspan=1>862.1145</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>JFP</td></tr><tr><td rowspan=1 colspan=1>Lithium Test System</td><td rowspan=1 colspan=1>862.3560</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>JIH</td></tr></table>

Predicate Devices:

Statement of Technology Characteristics of the Device Compared to Predicate Device   

<table><tr><td rowspan=1 colspan=1>Description</td><td rowspan=1 colspan=1>510(k)</td><td rowspan=1 colspan=1>Measurand</td></tr><tr><td rowspan=1 colspan=1>AVL 9180</td><td rowspan=1 colspan=1>K961458</td><td rowspan=1 colspan=1>Sodium, Potassium, Chloride, Calcium and Lithium</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Operating Principle</td><td rowspan=1 colspan=1>Predicate Device</td><td rowspan=1 colspan=1>SMARTLYTE</td></tr><tr><td rowspan=1 colspan=1>Potentiometric Na*, K, Cr, Ca*, Lit</td><td rowspan=1 colspan=1>K961458</td><td rowspan=1 colspan=1>Same</td></tr></table>

# (7) Indications for Use:

TAoalzhii mentasalcaho loo ilu

T SMARTLYTESdAssy  tende easue di wholeblooe plas re-ilut alyAlolynalyztai  evic elecrolyte balance n the diagnosis and treatment of aldosteronism excessiv secretion  tehormoe yesnAo u ctiondlneyratip antidiuretichormone secretion, or other diseases involving electrolyte imbalance.

Th SMARTLYTE otassi Assay i intende measue potassn whole bloo eru plasaun lyaMeaentta ydevismnlolyalaneo treatment of diseases conditions characterized by low or high blood potassium levels:

TA o such as cystic fibrosis and diabetic acidosis.

T ARTLTECalcss eeasic eve i hole bloopas cet  prs diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms).

TAsyheha ho p treatment  patients wit mental isturbances, such as mani-depressiv iless bipolar isorer).

# Device Descriptions:

T Aa leolynalyzhi can r pas who bloope aly k6) which tests serum, plasma, whole blood, pre-diluted urine samples, and QC materialsBoth are microprocessor-controlled analyzers which utilize ion-selective electrodes for the measurement f sodium, sihlocchi e la whol bloo eiludurie sple olutins and CmaterialsThe nalyzer sef-calibrates using Diamon Dagnostics Flui Pack (510(k)3850 uy , hl  c mnam pt iolr r al Mis  h quality control material to be used daily.

# (9)Technological Characteristics of the Device:

# Principal of Measurement

T priciplesmeasements use n he MARTLYTEElecrolynalyzenticl hos pripe hu MARLTeoynalyzn8(K958 y equivalent to the K823480 (IL Flame Photometer) and K810615 (925 Chloridometer).

TSMARTLYTEmeasures sod, potasshloride an calci n ialysasi n selectiv el olyTe lecrd contai  gas ub ecalulat  sitiv The potassium and calcium each incorporate neutral carrierionophore membranes which are highly selective ivah aivey ha lulat l lise y vsivtratal olutee pontv the concentration of the ion sensed by the electrode.

# Comparison to Predicate Devices:

Thsotwareas beenodi o a DalysatemodeIndit ehardware was hanged allosvi m han mpcaliatin esult anincre sorage capacity  we Mov FD bas   al n pcks n  f All oer unctionality has remained unchanged from the Predicate SMARTLTYE The Dialysate Mode added is similar to the 9180 Bicarbonate Dialysate Mode.

The table below compares the Candidate Device to its predicates.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Candidate Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Trade/proprietary name</td><td rowspan=1 colspan=1>Diamond Electrolyte Analyzer</td><td rowspan=1 colspan=1>Roche Electrolyte Analyzer</td></tr><tr><td rowspan=1 colspan=1>Model number</td><td rowspan=1 colspan=1>SMARTLYTE</td><td rowspan=1 colspan=1>9180</td></tr><tr><td rowspan=1 colspan=1>Manufacturer</td><td rowspan=1 colspan=1>Diamond Diagnostics Corp</td><td rowspan=1 colspan=1>Roche Diagnostics GmBh</td></tr><tr><td rowspan=1 colspan=1>510(k)/PMA reference number</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>K961458</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>Sodium, Potassium, Chioride, Calcium, LithiumDetermination</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Blood, serum, plasma, urine, aqueous QC, Dialysate</td><td rowspan=1 colspan=1>Also has Acetate Dialysate Mode</td></tr><tr><td rowspan=1 colspan=1>Measurement Principle</td><td rowspan=1 colspan=1>Ion Selective Electrodes</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analysis time</td><td rowspan=1 colspan=1>57 sec</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measurement Range, Whole Blood, Plasma, Serum, Dialysate</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Na40 - 200 mEq/L</td><td rowspan=1 colspan=1>40 - 205 mEq/L</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>K1.7-15 mEq/L</td><td rowspan=1 colspan=1>1.5 - 15 mEq/L</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>CI50 - 200 mEq/L</td><td rowspan=1 colspan=1>50 - 200 mEq/L</td></tr><tr><td rowspan=1 colspan=1>Ca</td><td rowspan=1 colspan=1>0.3 - 5 mmol/L</td><td rowspan=1 colspan=1>0.2 -5.0 mmoVL</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Li0.2 - 5.5 mEq/L</td><td rowspan=1 colspan=1>0.1-6.0 mEq/L</td></tr><tr><td rowspan=1 colspan=1>Measurement Range, Urine</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Na3 -300 mEq/L</td><td rowspan=1 colspan=1>1-300 mEq/L</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>K5 -120 mEq/L</td><td rowspan=1 colspan=1>4.5-120 mEq/L</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>CI 15 -300 mEq/L</td><td rowspan=1 colspan=1>1 - 300 mEq/L</td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>≤1%</td><td rowspan=1 colspan=1>≤1%</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>≤2%</td><td rowspan=1 colspan=1>≤1%</td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>≤1.5%</td><td rowspan=1 colspan=1>≤2%</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>≤3%</td><td rowspan=1 colspan=1>≤3%</td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>≤1%</td><td rowspan=1 colspan=1>≤1%</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>≤3%</td><td rowspan=1 colspan=1>≤1%</td></tr><tr><td rowspan=1 colspan=1>Expected, within run sd</td><td rowspan=1 colspan=1>≤ 0.02</td><td rowspan=1 colspan=1>≤ 0.02</td></tr><tr><td rowspan=1 colspan=1>Expected, between run sd</td><td rowspan=1 colspan=1>≤0.06</td><td rowspan=1 colspan=1>≤0.04</td></tr><tr><td rowspan=1 colspan=1>Expected, within run sd</td><td rowspan=1 colspan=1>≤0.03</td><td rowspan=1 colspan=1>≤0.02</td></tr><tr><td rowspan=1 colspan=1>Expected, between run sd</td><td rowspan=1 colspan=1>≤0.09</td><td rowspan=1 colspan=1>≤ 0.08</td></tr><tr><td rowspan=1 colspan=1>Urine Precision, Na</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Y</td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>≤5%</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>≤5%</td><td rowspan=1 colspan=1>≤7%</td></tr><tr><td rowspan=1 colspan=1>Urine Precision, K</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Y</td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>≤5%</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>≤5%</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Urine Precision, CI</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>≤5%</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>≤5%</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibration</td><td rowspan=1 colspan=1>Automatic and on Demand</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reagent Pack</td><td rowspan=1 colspan=1>Standard A 350 mlStandard B 85 mlStandard C 85 mlReference Sotution 85 mlWaste bagRW RFID Tag for monitoring individual fluid packconsumption</td><td rowspan=1 colspan=1>No RFID Tag</td></tr><tr><td rowspan=1 colspan=1>Results Storage</td><td rowspan=1 colspan=1>Measurement results, 1000QC Levels 1, 2, 3 results, each 500Calibration Results, 5</td><td rowspan=1 colspan=1>Measurement results, 1QC Levels  esuts, tal Calibration Results, 1</td></tr><tr><td rowspan=1 colspan=1>Output</td><td rowspan=1 colspan=1>32 character, 2 line alphanumenic displaythermal printerRS-232 Serial portUSB ports (2)RFID Board to R/W RFID Ta</td><td rowspan=1 colspan=1>SameSsameSame</td></tr><tr><td rowspan=1 colspan=1>Power</td><td rowspan=1 colspan=1>100-115 ~ VAC 50-60 Hz, 0.8 Aor220-VAC 50/60 Hz, 0.4 A</td><td rowspan=1 colspan=1>SameSameSame</td></tr></table>

TARLE ps  -oalaion 3-po alat h)vy urse peits caliration n demand-point calibration s performed automaticlly with each measurement

Technical Specifications: Analyzer tests samples for Na\*/K\*/Cl/Ca†/Lit\*

Sample Types: Whole Blood, Serum, Plasma, Urine, Dialysate

# Sample Size:

95uL blood, plasma, serum, dialysate   
95uL 1:3 dilution of urine

Measurement Range: Parameter Matrix

Specified range Na+ B/P/S/D/Q 40 - 200 mEq/L U 1 - 300 mEq/L K+ B/P/S/D/Q 1.5 - 15 mEq/L U 5 - 120 mEq/L (60 - 120 mEq/L with additional dilutions) CI- B/P/S/D/Q 50 - 200 mEq/L U 1 - 300 mEq/L iCa++ B/P/S/D/Q 0.3 - 5 mmol/L Li+ B/P/S/Q 0.2 - 5.5 mEq/L

$\mathsf { B } =$ Whole blood P = Plasma S = Serum $\bigcirc =$ Aqueous QC U $=$ Urine . $\mathsf { D } =$ Dialysate

# Display Resolution:

Blood, Plasma, Serum, Dialysate, Aqueous QC

Na: 0.1 mEq/L  
$\mathsf { K } ^ { + }$ 0.1 mEq/L or 0.01 mEq/LCr: 0.1 mEq/L  
Cat: 0.1 mmol/L or 0.01 mmol/LLit: 0.1 mEq/L or 0.01 mEq/L

Urine Na: 0 mEq/L K: 0.1 mEq/L Cr: 0 mEq/L

# Reproducibility:

Blood, Plasma, Serum, Dialysate

<table><tr><td></td><td>Na</td><td>K*</td><td>cr</td><td></td><td>Ca**</td><td>Li*</td></tr><tr><td>Within Range (n=30)</td><td>C.V. ≤ 1%</td><td>C.V. ≤ 1.5%</td><td>C.V.≤ 2%</td><td></td><td>SD ≤ 0.02</td><td>SD ≤ 0.03</td></tr><tr><td>Between Run (10 days)</td><td>C.V. ≤ 2%</td><td>C.V. ≤ 3%</td><td>C.V.≤ 3%</td><td></td><td>SD ≤ 0.06</td><td>SD ≤ 0.09</td></tr></table>

# Urine

Na K\*. cr Within Range $( n = 3 0 )$ C.V.≤ 5% C.V.≤ 5% C.V.≤ 5% Between Run (10 days) C.V. ≤ $5 \%$ C.V.≤ 5% C.V. ≤ $5 \%$

Analysis Time 57 seconds

# Calibration

Every 4 hours, on demand 2 point calibration Na\*, K\*, Cr,Ca\* 3 point calibration Lit†

Power   
120 VAC 5 Hz, 6 A or 220-240 VAC 24 Hz, 2 A (Factory set)

Size and Weight 12.4" (31.5cm) W x 13.2" (33.5cm) H x 11.6" (29.5cm) D, 13 lbs. (<6 kg)

Summary f nonclinical tests submitted with the premarket notification or device.

Precision - Whole blood, serum, plasma and urine were previously cleared (K082462).

Within run precision was calculated from three dialysate samples for each measurand. The sample concentrations were a the low and high end of reference ranges and near the mid point range.The procol ca  g 0lica  sple wot caliratin bewee eaentsTeliat run consecutively in one day.

Within Run Na+ C.V.≤ 1% K+ C.V. ≤ $2 \%$ EPY CI- C.V.≤ $2 \%$ $\cos + +$ SD ≤ 0.02

Total precision was calculated for 3 samples with concentrations spanning the reportable range. The dialys amples wenn groups   wi a clatin betwen each group epliate. Ths procedure was adopted due to the inherent instability of Calcium in the carbonate/bicarbonate environment which would result in Ca shifts.

Dialysate Between Run Na+ C.V. ≤ $2 \%$ K+ C.V.≤ 3%

CI- C.V.≤ 3% Ca++ SD ≤ 0.06

Precision Dialysate, mEq/L   

<table><tr><td rowspan=1 colspan=1>Within Run</td><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>K+</td><td rowspan=1 colspan=1>CI-</td><td rowspan=1 colspan=1>$C_a{</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>122.45</td><td rowspan=1 colspan=1>2.7073</td><td rowspan=1 colspan=1>83.93</td><td rowspan=1 colspan=1>0.8013</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.39</td><td rowspan=1 colspan=1>0.0235</td><td rowspan=1 colspan=1>0.75</td><td rowspan=1 colspan=1>0.0087</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.32</td><td rowspan=1 colspan=1>0.87</td><td rowspan=1 colspan=1>0.89</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>Run to Run</td><td rowspan=1 colspan=1>Na*</td><td rowspan=1 colspan=1>K+</td><td rowspan=1 colspan=1>CI-</td><td rowspan=1 colspan=1>Ca</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>122.41</td><td rowspan=1 colspan=1>2.7243</td><td rowspan=1 colspan=1>83.48</td><td rowspan=1 colspan=1>0.7975</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.40</td><td rowspan=1 colspan=1>0.0347</td><td rowspan=1 colspan=1>1.20</td><td rowspan=1 colspan=1>0.0076</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0:32</td><td rowspan=1 colspan=1>1.27</td><td rowspan=1 colspan=1>1.44</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td></tr></table>

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Na  1</td><td rowspan=1 colspan=1>K+</td><td rowspan=1 colspan=1>CI-  1</td><td rowspan=1 colspan=1>$Ca^</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>139.56</td><td rowspan=1 colspan=1>4.0400</td><td rowspan=1 colspan=1>107.32</td><td rowspan=1 colspan=1>1.2491</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.45</td><td rowspan=1 colspan=1>0.0111</td><td rowspan=1 colspan=1>0.35</td><td rowspan=1 colspan=1>0.0143</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.32</td><td rowspan=1 colspan=1>0.28</td><td rowspan=1 colspan=1>0.33</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>K+</td><td rowspan=1 colspan=1>CI-</td><td rowspan=1 colspan=1>Ca*</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>140.59</td><td rowspan=1 colspan=1>4.0718</td><td rowspan=1 colspan=1>107.91</td><td rowspan=1 colspan=1>1.2347</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.76</td><td rowspan=1 colspan=1>0.0359</td><td rowspan=1 colspan=1>0.58</td><td rowspan=1 colspan=1>0.0158</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.54</td><td rowspan=1 colspan=1>0.88</td><td rowspan=1 colspan=1>0.53</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td></tr></table>

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Na 1</td><td rowspan=1 colspan=1>K+</td><td rowspan=1 colspan=1>CI-</td><td rowspan=1 colspan=1>Ca</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>158.12</td><td rowspan=1 colspan=1>6.7653</td><td rowspan=1 colspan=1>123.05</td><td rowspan=1 colspan=1>1.7015</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.74</td><td rowspan=1 colspan=1>0.0265</td><td rowspan=1 colspan=1>0.29</td><td rowspan=1 colspan=1>0.0155</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.47</td><td rowspan=1 colspan=1>0.39</td><td rowspan=1 colspan=1>0.24</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Na*</td><td rowspan=1 colspan=1>K+</td><td rowspan=1 colspan=1>CI-</td><td rowspan=1 colspan=1>$Ca^$</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>158.77</td><td rowspan=1 colspan=1>6.7618</td><td rowspan=1 colspan=1>123.55</td><td rowspan=1 colspan=1>1.6788</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.30</td><td rowspan=1 colspan=1>0.0693</td><td rowspan=1 colspan=1>0.72</td><td rowspan=1 colspan=1>0.0226</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.51</td><td rowspan=1 colspan=1>1.02</td><td rowspan=1 colspan=1>0.59</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td></tr></table>

Linearity -Whole blood, serum, plasma and urine were previously cleared (K082462).

Linearity was evaluated by preparing stock solutions with high concentrations of Na\*, $\mathsf { K } ^ { + }$ CI and ${ \mathsf { C a } } ^ { \mathsf { i } + }$ aly ocweilu atins across ea n c nalyan mati ir ressn ws po  eult expected values based on the stock sample dilution. The results are shown below.

Dialysate, Measured compared to Expected Values, mEq/L   

<table><tr><td>Parameter</td><td>Slope</td><td>Intercept</td><td>R^{2}$</td><td>Range</td><td>Steyx</td><td>n</td></tr><tr><td>Sodium</td><td>0.9806</td><td>2.53</td><td>0.9995</td><td>24 -205</td><td>1.12</td><td>34</td></tr><tr><td>Potassium</td><td>1.0031</td><td>-0.37</td><td>0.9976</td><td>1.4 - 15.1</td><td>0.20</td><td>36</td></tr><tr><td>Chloride</td><td>0.9996</td><td>1.60</td><td>0.9998</td><td>40 - 202</td><td>0.74</td><td>34</td></tr><tr><td>Calcium</td><td>0.9857</td><td>0.06</td><td>0.9972</td><td>0.4 - 5.0</td><td>0.07</td><td>.48</td></tr></table>

The lnearity studies support the following reportable range.

Measuring Range Dialysate

Na: 40 - 200 mEq/LK: 1.7 - 15 mEq/LCl: 50 - 200 mEq/LCa: 0.3 - 5.5 mmol/L

Summary of clinical tests -Whole blood serum, plasma and urine were previously cleared (K0824).

Clinical testing was conducted demonstratehe correlation Dimond Diagnostc SMARTLYTEAnalyz predicat devi eratd by tai persl. Dialysates wecollecr stg on e ARTE a vRS p  pi n measuring ranges. The results are summarized below. Regression analysis show good correlation to predicate with correlation coeicients typically greater than 0.99 and slope values between 0.96 and 1.04.

# Dialysate Comparison SMARTLYTE versus AVL 9180 (k961458)

<table><tr><td>Parameter</td><td>Slope</td><td>Intercept</td><td>$R^{}$</td><td>Range</td><td>n</td><td>Styx</td></tr><tr><td>Sodium</td><td>1.0183</td><td>-2.52</td><td>0.9989</td><td>49&#x27;- 179</td><td>43</td><td>1.31</td></tr><tr><td>Potassium</td><td>0.9882</td><td>0.04</td><td>0.9996</td><td>1.5 - .14</td><td>56</td><td>0.08</td></tr><tr><td>Chloride</td><td>0.9825</td><td>2.86</td><td>0.9966</td><td>52 - 199</td><td>51</td><td>2.25</td></tr><tr><td>Calcium</td><td>1.0021</td><td>0.03</td><td>0.9956</td><td>0.25 - 4.5</td><td>43</td><td>0.08</td></tr></table>

The method comparison study supports correlation in the following reportablerange.

Measuring Range Dialysate

Na: 40 - 205 mEq/LK: 1.7 - 11 mEq/LCl: 50 - 205 mEq/LCa: 0.3 - 5.5 mmol/L

# (12)Conclusions drawn from the clinical and non-clinical testing.

Analysis of the dialysate comparative measurements presented in the $5 1 0 ( \mathsf { k } )$ for this device, together with the Diagnostics SMARTLYTE Electrolyte Analyzer (with $N a ^ { + }$ $\mathsf { K } ^ { + }$ C  i equivalent to the predicate devices, AVL 9180 (k961248).

Diamond Diagnostics, Inc. c/o Kathy Cruz   
333 Fiske St.   
Holliston, MA 01746

Re: k121040 Trade Name: SMARTLYTE Electrolyte Analyzer Regulation Number: 21 CFR §862.1665 Regulation Name: Sodium test system Regulatory Class: Class II Product Codes: JGS, CEM, CGZ, JFP, JIH Dated: August 2, 2012 Received: August 3, 2012

Dear Kathy Cruz:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with al the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical   
Devices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance...

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm

Sincerely yours,

2

Couptney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (if known): k121040

Device Name: SMARTLYTE Electrolyte Analyzer

Indications For Use:

The SMARTLYTE is an automated, microprocessor-controlled analyzer which utilizes ion-selective electrodes for the measurement of sodium, potassium, chloride, calcium and lithium in serum, plasma, whole blood, pre-diluted urine samples. In addition, the analyzer can also measure sodium, potassium, chloride and calcium in dialysate samples.

The SMARTLYTE Sodium Assay is intended to measure sodium in whole blood, serum, plasma, prediluted urine and dialysate on the SMARTLYTE Electrolyte Analyzer. Measurements obtained by this device are used to monitor electrolyte balance in the diagnosis and treatment of aldosteronism (exssive secretion  the hormoe aldosterone), diabetes insipidus (cronicexcretion  are amounts of dilute urine, accompanied by extreme thirst), adrenal hypertension, Addison's disease (caused by destruction of the adrenal glands), dehydration, inappropriate antidiuretic hormone secretion, or other diseases involving electrolyte imbalance.

The SMARTLYTE Potassium Assay is intended to measure potassium in whole blood, serum, plasma, urine and dialysate. Measurements obtained by this device are used to monitor electrolyte balance in the diagnosis and treatment of diseases conditions characterized by low or high blood potassium levels.

The SMARTLYTE Chloride Assay is intended to measure the level of chloride in whole blood, serum, plasma, urine and dialysate. Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

The SMARTLYTE Calcium Assay is intended to measure ionized calcium levels in whole blood, plasma, serum, and dialysate. Calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms).

The SMARTLYTE Lithium Assay is intended to measure lithium (from the drug lithium carbonate) in wo blo plasa n rMet  l eus  assehat e pro dosage is administered in the treatment of patients with mental disturbances, such as manic-depressive illness (bipolar disorder).

And/Or

Prescription Use _ X (21 CFR Part 801 Subpart D)

Over the Counter Use (21 CFR Part 801 Subpart C)